Skip to main content

Saturday, July 20:  All UR Medicine facilities are open as scheduled and providing safe patient care, with a goal to return all clinical services to full efficiency by early next week.
Patients: click here for more information. Faculty/Staff: click here for information.

menu

About the Program

  • Hematology/Oncology fellows work with internationally recognized faculty in disease-specific clinics.
  • Fellows receive in-depth clinical training in benign hematology, hematologic malignancies, consultative oncology, and oncologic subspecialties, and bone marrow transplantation and CAR-T cell therapy.
  • Fellows cultivate academic careers through individualized opportunities for mentorship in clinical, basic, or translational research, hematology, oncology, and bone marrow transplantation.
  • Fellows participate in thematic disease-specific didactic lectures series, participate in cancer survivorship workshops, receive lectures on work-life balance/time management, clinical trial design and research conduct, database design and analysis, bioinformatics, cancer disparities, geriatric oncology, quality improvement, and cancer biology.
  • Fellows participate in journal club, self-reflective narrative writing, M & M/Quality conferences, and give clinical and research presentations.
  • Fellows attend the weekly Wilmot Cancer Institute Scientific Symposia featuring international experts in basic and clinical cancer research from around the world.
  • Fellows receive membership to SWOG, ASH, and ASCO, and receive access to ASCO SEP and ASH SAP for board review materials.
     

The first year

Our fellowship program provides in-depth clinical training in benign hematology, hematologic malignancies, consultative oncology, and oncologic subspecialties, and bone marrow transplantation and CAR-T cell therapy. First-year fellows divide their time among the Wilmot Cancer Institute, Highland Hospital, and Comprehensive Breast Care at Pluta. These combined training experiences provide inpatient and ambulatory hematology and oncology care to patients from around our region and beyond.

The first year of training is organized around disease-specific clinics and inpatient medicine. Fellows are supervised directly by faculty mentors in each disease-specific area. Fellows also attend a wide variety of teaching conferences at Wilmot and have access to the weekly Wilmot Scientific Symposia. 

Beyond the first year

A high faculty-to-fellows ratio affords individualized opportunities for mentorship in several areas. Our fellows have direct access to faculty mentors in clinical, basic, or translational research, hematology, oncology, and bone marrow transplantation. Our faculty is devoted to helping fellows achieve their career aspirations, and early career development is fostered and encouraged. Fellows receive protected time and are encouraged to develop research and career goals while growing ongoing expertise in specialized patient care. During this protected time, fellows develop skills in clinical and translational research through elective pursuit of a master’s degree, participation in our year-long Clinical Research Methodology Curriculum (dedicated to research methodology and its application), training in quality improvement methods, and a variety of other interests. Academic productivity and success are facilitated by frequent meetings with preceptors and mentors.

Requirements

Qualified applicants have completed three years of ACGME-accredited Internal Medicine Residency training and are eligible to take the American Board of Internal Medicine examination.

At the University of Rochester, we’re fueled by a relentless quest to improve humankind and it starts with our residents and fellows. We’re pushing. We’re questioning. We’re constantly evolving the ways we learn, discover, heal and create—and opening eyes to a new worldview.

Watch how they embrace Meliora. Ever better.